The FDA has approved a blood test for colon cancer screening, making it more accessible. Patients faced $895 out-of-pocket costs for the test, now more likely to be covered by insurance.
Dr. David Chung hails this FDA approval as a 'tremendous leap forward' for CRC screening, potentially leading to life-saving early interventions.
While not a substitute, the blood test complements existing screenings and can help bridge the gap in screening rates, potentially saving more lives through early detection.
Colorectal cancer cases are rising, especially in younger individuals, emphasizing the importance of early treatment and screening options like this newly approved blood test.
Collection
[
|
...
]